解决克里斯帕-卡斯9基因组编辑系统在大肠杆菌中的毒性和效率之间的权衡
Qian Guo1,2,3, Qi Shen1,2,3, Qi Hao1,2,3
1Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Biotechnology journal
|April 1, 2025
概括
这项研究引入了一种优化的CRISPR-Cas9系统,用于对大肠杆菌BL21 (DE3) 进行高效的基因组编辑,克服了蛋白质表达应用之前的毒性和效率权衡.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 大肠杆菌BL21 (DE3) 是异质蛋白表达的关键宿主.
- 对于大肠杆菌BL21 (DE3) 的现有CRISPR-Cas9系统面临效率和毒性方面的挑战.
- 有效的基因编辑对于优化大肠杆菌菌株的工业和学术应用至关重要.
研究的目的:
- 为大肠杆菌BL21 (DE3) 开发一个改进的CRISPR-Cas9基因组编辑系统.
- 解决CRISPR-Cas9中介基因编辑中的效率-毒性权衡问题.
- 增强大肠杆菌作为蛋白质表达和合成生物学的主体的实用性.
主要方法:
- 在编辑阶段使用高复制等离子体暂时诱导Cas9表达.
- 使用温度敏感的复制体来消除sgRNA等离子体.
- 使用SacB系统去除表达Cas9的等离子体.
- 开发了pEBcas9/pEBsgRNA系统,用于优化CRISPR-Cas9基因组编辑.
主要成果:
- 通过短暂的Cas9表达实现了高效的基因组编辑,减轻了毒性.
- 与以前的方法相比,编辑系统的删除效率被证明更高.
- 在大肠杆菌BL21 (DE3) 中成功进行了五轮基因组编辑和同时多位点编辑.
- 确定了适合用于外源基因多副本综合表达的位置.
结论:
- 该pEBcas9/pEBsgRNA系统提供了一个有效和强大的解决方案,用于在大肠杆菌BL21 (DE3) 中进行CRISPR-Cas9基因组编辑.
- 这种优化的系统克服了以前的局限性,促进了复杂的遗传修饰.
- 该系统具有广泛的潜力,可以促进大肠杆菌在工业生物技术和学术研究中的应用.
相关概念视频
CRISPR
48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K
Homologous Recombination
49.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
49.9K
CRISPR and crRNAs
16.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.4K


